Insider Trading History of Gill Simba

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Gill Simba since 2022. This trader's CIK number is 1180763. At the time of last reporting, Gill Simba was the President & CEO of Evelo Biosciences, Inc.. (stock ticker symbol EVLO). Also see all insider trading activities at Evelo Biosciences, Inc..

Note that in the past GILL SIMBA also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Evelo Biosciences, Inc. (EVLO) by Gill Simba

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 EVLO 0 $0 6,047 $11,617 40,780 $0

Yearly summary of insider trading at Foghorn Therapeutics Inc. (FHTX) by Gill Simba

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 FHTX 0 $0 0 $0 82,000 $59,860


Insider trading activities at 2 companies by Gill Simba:

1. Evelo Biosciences, Inc. (EVLO)

2. Foghorn Therapeutics Inc. (FHTX)

Table 1. Insider trading of Evelo Biosciences, Inc. (EVLO) by Gill Simba

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-11-08 EVLO Sale 172 .33 56
2023-11-07 EVLO Option Ex 1,172 .00 0
2023-09-28 EVLO Sale 1,996 3.94 7,864
2023-09-27 EVLO Option Ex 15,000 .00 0
2023-08-08 EVLO Sale 342 9.51 3,252
2023-08-07 EVLO Option Ex 1,171 .00 0
2023-05-08 EVLO Sale 3,537 .13 445
2023-05-07 EVLO Option Ex 23,437 .00 0

Table 2. Insider trading of Foghorn Therapeutics Inc. (FHTX) by Gill Simba

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-09-12 FHTX Option Ex 82,000 .73 59,860

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gill Simba (President & CEO of Evelo Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.